Jonathan Lorenzana
Foot Surgery · San Antonio, TXNPI 1194130880
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,380 of the $3,536 with a category attached, or 67.3%. 14 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 42.7% of the total. 2025 is the largest year on record at $1,102, 8.2 times the $135 reported in 2019.
Across 63 payments — averaging $56.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Mission Medical Distribution, LLC$574
- Stryker$311
- Biocomposites Inc$300
- Imbed Biosciences Inc.$280
- Orthofix Medical, Inc.$234
- plus $328 from 8 others
What the payments were for
- Travel & lodging$1,15533%
- Food & beverage$2,38067%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 18 | $1,509 |
| Mission Medical Distribution, LLC | 4 | $574 |
| Stryker | 2 | $311 |
| Biocomposites Inc | 2 | $300 |
| Imbed Biosciences Inc. | 11 | $280 |
| Orthofix Medical, Inc. | 12 | $234 |
| Anika Therapeutics, Inc. | 3 | $82 |
| Osteomed LLC | 1 | $73 |
| Smith+Nephew | 3 | $48 |
| Indivior Inc. | 2 | $31 |
| Arthrex | 1 | $30 |
| Kerecis Limited | 2 | $23 |
| Integra Lifesciences Corporation | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$815
- Stimulan$300
- N/A$167
- AXSOS$144
- TRUELOK SYSTEM$122
- Trinity ELITE$122
- TrueLok$122
- LAPIPLASTY SYSTEM 1$118
How this compares
$3,536 in reported general payments places this provider in the 60th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 214 | $6,314 |
| Clotrimazole | 71 | $1,286 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $354 |
| Doxycycline Hyclate | 17 | $277 |
| Gabapentin | 25 | $186 |
| Methylprednisolone | 22 | $166 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in San Antonio
- Marque AllenSan Antonio$204K
- Lawrence LaverySan Antonio$59K
- Richard KehSan Antonio$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Joshua WardSan Antonio$5K
- Caroline GaynorSan Antonio$2K
- Jason MirelesSan Antonio$1K
- Marvin SanchezSan Antonio$614
- W Brent GillespieSan Antonio$383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.